A microsimulation model has quantified what clinicians have long suspected: sustained steroid exposure in autoimmune disease carries a measurable, and avoidable, clinical and economic burden that ...
Pharmaceutical companies need to replace dose reduction measures with direct toxicity measurement in health-economic models Dose reduction overlooks the hidden healthcare costs of steroid-toxicity. ...
“Steroids are cheap and effective in the short term. Convincing payers that steroid-sparing therapies are worth the upfront cost is still a practical challenge.” Albert Whangbo, PhD, leads the global ...
Ten years ago, two clinical researchers walked into a bar and, over a beer, asked themselves whether the direct measurement of steroid-toxicity would ever be possible. Today, Steritas, in licensing ...
Despite their seemingly miraculous efficacy, the long-term adverse effects of glucocorticoids pose significant challenges. This reality led Ali A. Habib, MD and Pushpa Narayanaswami, MD to author an ...